[go: up one dir, main page]

Capron et al., 1990 - Google Patents

The IgE receptor of eosinophils

Capron et al., 1990

Document ID
5374680800188560621
Author
Capron M
Prin L
Publication year
Publication venue
Springer seminars in immunopathology

External Links

Snippet

Most cells involved in the immune response express Fc receptors for immunoglobulins, including receptors for IgE or Fc, R. For some time, it was believed that IgE interacts only with Fc, R on basophils and mast cells, until the original observations of Capron et al.[13] …
Continue reading at link.springer.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Similar Documents

Publication Publication Date Title
Kroegel et al. Pulmonary immune cells in health and disease: the eosinophil leucocyte (Part I)
Abu-Ghazaleh et al. IgA-induced eosinophil degranulation.
EP1576368B1 (en) Methods and compositions for enhancing fibrocyte formation
Hartnell et al. IFN-gamma induces expression of Fc gamma RIII (CD16) on human eosinophils.
Wolf et al. Anti‐inflammatory properties of human serum IgA: Induction of IL‐1 receptor antagonist and FcαR (CD89)‐mediated down‐regulation of tumour necrosis factor‐alpha (TNF‐α) and IL‐6 in human monocytes
US10716832B2 (en) Compositions and methods for the systemic treatment of arthritis
Capron et al. The Second Receptor for IgE in Eosinophil
DE69333760T2 (en) EVALUATION OF PATIENTS WITH PROGRESSIVE IMMUNOSUPPRESSION
Kelly et al. IL-8 secretion and neutrophil activation by HT-29 colonic epithelial cells
JPH04504127A (en) Intercellular adhesion molecules and their binding ligands in the treatment of asthma
Walsh et al. Effects of cetirizine on human eosinophil and neutrophil activation in vitro
Kita et al. Eosinophils and IgE receptors: a continuing controversy
Nüsslein et al. Interleukin‐4 induces both lgg4 and ige secretion by peripheral blood b cells
Hiserodt et al. Laminin inhibits the recognition of tumor target cells by murine natural killer (NK) and natural cytotoxic (NC) lymphocytes
Capron et al. The IgE receptor of eosinophils
EP0648499B1 (en) Composition for inhibiting IgE production
Jewett et al. Pentoxifylline suppresses interleukin-2-mediated activation of immature human natural killer cells by inhibiting endogenous tumor necrosis factor-alpha secretion
Capron et al. Eosinophil IgE receptor and CD23
Thomas Basophil and Eosinophil Interactions in
EP1367393A1 (en) Methods for using the CD 163 pathway for modulating an immune response
Yarovinsky et al. Integrin receptors are crucial for the restimulation of activated T lymphocytes
Pawankar Mast cell function modulating IgE-mediated allergy
WO2004012763A1 (en) Modulation of mesenchymal cells via iga-receptors
Zielen et al. Defective CD2 T cell pathway activation in common variable immunodeficiency (CVID)
US20220193092A1 (en) Progestogen for use in the treatment of cytokine release syndrome